Research
Molecular
Metabolic drugs such as GLP-1-based therapies and SGLT2 inhibitors have benefits that extend beyond metabolic improvements into changes in chronic inflammation.
Practitioners should consider the anti-inflammatory potential of metabolic drugs in clinical settings.
StrongSupportsmedium confidence
With their expanded use, it is emerging that the benefits of these drugs extend beyond metabolic improvements into changes in chronic inflammation, potentially independent of those in metabolism.
Why this rating
The abstract discusses established clinical management and emerging evidence.
Source
Repurposing metabolic drugs as anti-inflammatory agents
Andrew E. Hogan et al. · Trends in Endocrinology and Metabolism · 2025
reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →